METHOD.
According to the previously reported N-terminal amino acid sequence of antiepilepsy peptide (1) , two degenerate primers were designed and synthesized. Total RNA was isolated from scorpion telsons and reverse transcribed. RACEs were performed. The PCR product was cloned and sequenced. The putative mature anti-neuroexcitation peptide (ANEP) encoding cDNA was then cloned into pET28a expression plasmid. Recombinant ANEP was purified by His-Bind affinity column. The resulting elute was desalted and concentrated with Amicon stirred ultrafiltration cells (1kDa membrane). Then the protein was further purified on Superdex 30 chromatography and analyzed by SDS-PAGE. Anti-neuroexcitation bioassay was performed essentially according to Xu et al (2) by using thiosemicarbazide induced mice convulsion model. Physiologic saline was used as blank control, sodium phenobarbital (4.0mg/kg) as positive control and recombinant anti-neuroexcitation peptide (2.0mg/kg) as sample respectively. The delayed time on the seizure of convulsive symptom in ANEP group and positive group, in comparison with the control group, was expressed in percentage of the control group and was used as indicator of anti-neuroexcitation biological activity. The cDNA sequence has been submitted to GenBank under accession number AF122003.
RESULTS.
Anti-neuroexcitation peptide (ANEP) totally has 82 amino acids, and the first 20 amino acids are supposed to be signal peptide. There are eight cysteines, about 12%, in ANEP. It is homologous to anti-epilepsy peptide, 63% similarity in the corresponding amino acid sequence, but have obvious differences in amino acid sequence. The cDNA encoding mature scorpion anti-neuroexcitation peptides was cloned into expression plasmid pET28a, fused to six consecutive histidines at its C-terminal. Recombinant ANEP was expressed upon IPTG induction and was about 15% of total cellular proteins, with most products aggregated in the insoluble inclusion body form. After sonication, the supernatant fraction was passed over the Ni 2+ -His-Bond column, and eluted by 1M imidazole, 0.5M NaCl, 20mM Tris-HCl, pH7.9. The elution fraction was desalted by ultra-filtration, further purified with Superdex 30 column. Recombinant ANEP was purified to homogeneity with the purity over 95% analyzed by SDS-PAGE. The overall recovery yield from the supernatant fraction after two-step chromatography was 0.7%. About 3mg pure recombinant ANEP-Ile-Glu-His 6 was obtained from 2 liters of flask culture. The anti-neuroexcitation activity of purified ANEP-Ile-Glu-His 6 was assayed on the animal model of convulsion induced by thiosemicarbazide. Comparing with the saline control, 2.0mg/kg of recombinant ANEP could display 18.0% delay in the convulsive seizure (p<0.01) and thus showed distinct anti-neuroexcitation biological activity. ANEP also has positive impact on Calcium channels in CNS neurons. The peptide-induced enhancement of Calcium currents is obvious and reversible. Further study is going one to investigate its biochemical, biophysical and pharmaceutical properties and the potentials as therapeutic peptide.
